ArticleOncology letters2017

Sorafenib therapy following resection prolongs disease-free survival in patients with advanced hepatocellular carcinoma at a high risk of recurrence.

Yadi Liao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.